Richard Saitz, MD

Richard Saitz MD, MPH, FACP (Fellow, American College of Physicians), DFASAM (Distinguished Fellow, American Society of Addiction Medicine), is a general internist (diplomate of the American Board of Internal Medicine, DABIM) and primary care physician, an addiction medicine specialist (diplomate of the American Board of Addiction Medicine, DABAM), Chair and Professor of Community Health Sciences at Boston University (BU) School of Public Health, and Professor of Medicine at BU School of Medicine. He Chaired the Treatment and Services review committee for the National Institute on Alcohol Abuse and Alcoholism, is Editor of Evidence-Based Medicine, associate editor of JAMA, and Senior Editor of Journal of Addiction Medicine, Section Editor and sole author of key chapters in UpToDate on unhealthy substance use, an editor of the ASAM Principles of Addiction Medicine textbook, Editor Emeritus of Addiction Science & Clinical Practice, and author of over two hundred peer-reviewed publications.

He was Director of Boston Medical Center’s Clinical Addiction Research and Education (CARE) Unit for over a decade, has been Chairman of an Institutional Review Board, Associate Director of Clinical Research for BU, President of the Association for Medical Education and Research in Substance Abuse (AMERSA), steering committee member of the Motivational Interviewing Network of Trainers (MINT), and is coordinating committee member of International Network for Brief Intervention for Alcohol and other drug problems (INEBRIA). He is on the International Society of Addiction Journal Editors (ISAJE) Board now as Vice President. His primary areas of expertise supported by NIH, RWJF, and SAMHSA, are screening and brief intervention, integrating substance-related and general health care, improving the quality of care for people with unhealthy substance use, particularly in general health settings, and basing care on science. He validated single-item screening questions recommended by NIDA and NIAAA. Awards: Alpha Omega Alpha Honor Society, Boston Jaycees Ten Outstanding Young Leaders Award, Best Doctors in America®, AMERSA’s W. Anderson Spickard, Jr. Excellence in Mentorship Award, the R. Brinkley Smithers Distinguished Scientist Award (ASAM), Research Society on Alcoholism Distinguished Researcher Award.

Chair
Boston University School of Public Health
Community Health Sciences


Professor
Boston University School of Medicine
Medicine
General Internal Medicine

Active Staff Privileges
Boston Medical Center
Medicine




Institutional Program Unifying Population and Laboratory Based Sciences Award
02/01/2013 - 01/31/2019 (Co-PI)
PI: Lindsay Farrer, PhD
Burroughs Wellcome Fund


URBAN ARCH (5/5) Boston Cohort - Alcohol and HIV-associated comorbidity and complications: Frailty, Functional impairment, Falls, and Fractures (the 4F Study)
09/01/2016 - 08/31/2018 (PI)
NIH/National Institute on Alcohol Abuse
2U01AA020784-06

Oral v Injection Naltrexone in Hospital: Comparative Effectiveness for Alcoholism
09/25/2014 - 08/31/2018 (PI)
NIH/National Institute on Alcohol Abuse
5R01AA021335-03

The National Drug Abuse Treatment Clinical Trials Network
09/01/2015 - 05/31/2018 (PI)
McLean Hospital Corporation NIH NIDA
5UG1DA015831-15

Relational Agent to Improve Alcohol Screening and Treatment in Primary Care
12/01/2016 - 01/31/2018 (PI)
VA Boston Healthcare System Department of VA


Personnel Agreement for Research Service of Richard Saitz
08/01/2014 - 09/14/2015 (PI)
VA Boston Healthcare System


Center to Prevent Alcohol Problems Among Young People
02/01/2004 - 01/31/2010 (Co-PI)
NIH/National Institute on Alcohol Abuse and Alcoholism
3 P60 AA13759 05S1

Net Lifetime Health Effects of Alcohol Use and Abuse
05/16/2003 - 04/30/2008 (Co-PI)
NIH/National Institute on Alcohol Abuse and Alcoholism
5 R01 AA13304 03

Faculty Development Program Grant
09/30/1998 - 03/29/2002 (Co-PI)
PI: Jeffrey H. Samet, MD, MA, MPH
HHS/SAMHSA/Center for Substance Abuse Prevention
5 T26 SP08355 03

Improving Rates of Physician Intervention for Alcohol Problems
07/01/1997 - 06/30/2001 (PI)
Robert Wood Johnson Foundation


SBIRT for Substance Abuse in Mental Health Treatment Settings
09/15/2012 - 08/31/2017 (PI)
Univ of California, Los Angeles NIH-NIDA

Addressing Alcohol/HIV Consequences in Substance Dependence-Boston ARCH Cohort (Supplement)
03/05/2015 - 08/31/2016 (PI)
NIH-NIAAA

Addressing Alcohol /HIV Consequences in Substance Dependence - Boston ARCH Cohort
09/20/2011 - 08/31/2016 (PI)
NIH-NIAAA

Efficacy/Effectiveness of Unhealthy Drug Use Screening
05/01/2012 - 04/30/2015 (PI)
NIH-NIDA

Efficacy/Effectiveness of unhealthy drug use screening/Brief intervention models
07/01/2009 - 04/30/2015 (PI)
NIH-NIDA

Efficacy/Effectiveness of Unhealthy Drug Use Screening/Brief Intervention Models
07/15/2008 - 04/30/2015 (PI)
NIH-NIDA

Screening and Brief Intervention (SBI) Implementation and Sustainability
04/01/2011 - 12/31/2012 (PI)
NIH-NIDA

Validation for Self-administered Single-item Screening Questions (SISQ) for Drug Use
04/01/2012 - 09/30/2012 (PI)
MITRE Corporation HRSA-SAMHSA

Alcohol SBI Research Conference
12/10/2010 - 11/30/2011 (PI)
NIH-NIAAA

Linkage of Alcohol Abusers to Primary Care - Supplement
06/29/2006 - 08/31/2011 (PI)
NIH-NIAAA

Showing 10 of 14 results. Show All Results


Yr Title Project-Sub Proj Pubs
2017 Oral v Injection Naltrexone in Hospital: Comparative Effectiveness for Alcoholism 5R01AA021335-04 1
2017 URBAN ARCH (5/5) Boston Cohort - Alcohol and HIV-associated comorbidity and complications: Frailty, Functional impairment, Falls, and Fractures (the 4F study) 5U01AA020784-07 2
2016 Oral v Injection Naltrexone in Hospital: Comparative Effectiveness for Alcoholism 5R01AA021335-03 1
2016 URBAN ARCH (5/5) Boston Cohort - Alcohol and HIV-associated comorbidity and complications: Frailty, Functional impairment, Falls, and Fractures (the 4F study) 2U01AA020784-06 2
2015 Addressing Alcohol/HIV Consequences in Substance Dependence-Boston ARCH Cohort 3U01AA020784-04S1 2
2015 Oral v Injection Naltrexone in Hospital: Comparative Effectiveness for Alcoholism 5R01AA021335-02 1
2015 Addressing Alcohol/HIV Consequences in Substance Dependence - Boston ARCH Cohort 5U01AA020784-05 2
2014 Oral v Injection Naltrexone in Hospital: Comparative Effectiveness for Alcoholism 1R01AA021335-01A1 1
2014 Addressing Alcohol/HIV Consequences in Substance Dependence - Boston ARCH Cohort 5U01AA020784-04 2
2013 Addressing Alcohol/HIV Consequences in Substance Dependence - Boston ARCH Cohort 5U01AA020784-03 2
Showing 10 of 41 results. Show All Results
Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.

  1. Bagley SM, Hadland SE, Carney BL, Saitz R. Addressing Stigma in Medication Treatment of Adolescents With Opioid Use Disorder. J Addict Med. 2017 Nov/Dec; 11(6):415-416.View Related Profiles. PMID: 28767537.
  2. Lorkiewicz SA, Ventura AS, Heeren TC, Winter MR, Walley AY, Sullivan M, Samet JH, Saitz R. Lifetime Marijuana and Alcohol Use, and Cognitive Dysfunction in People with Human Immunodeficiency Virus Infection. Subst Abus. 2017 Oct 23; 0.View Related Profiles. PMID: 29058572.
  3. Kim TW, Walley AY, Ventura AS, Patts GJ, Heeren TC, Lerner GB, Mauricio N, Saitz R. Polypharmacy and risk of falls and fractures for patients with HIV infection and substance dependence. AIDS Care. 2017 Oct 16; 1-10.View Related Profiles. PMID: 29034725.
  4. Bertholet N, Cheng DM, Palfai TP, Lloyd-Travaglini C, Samet JH, Saitz R. Anxiety, Depression, and Pain Symptoms: Associations With the Course of Marijuana Use and Drug Use Consequences Among Urban Primary Care Patients. J Addict Med. 2017 Oct 09.View Related Profiles. PMID: 28984682.
  5. Chavez KE, Palfai TP, Squires LE, Cheng DM, Lloyd-Travaglini C, Saitz R. Perceived discrimination and drug involvement among black primary care patients who use drugs. Addict Behav. 2017 Sep 01; 77:63-66.View Related Profiles. PMID: 28965068.
  6. Saitz R, Daaleman TP. Now is the Time to Address Substance Use Disorders in Primary Care. Ann Fam Med. 2017 Jul; 15(4):306-308. PMID: 28694263.
  7. Saitz R. Editor''s Note: Congratulations to the 2017 Author and Reviewer Award Winners. J Addict Med. 2017 Jul/Aug; 11(4):245. PMID: 28759545.
  8. Saitz R. Valid, Reproducible, Clinically Useful, Nonstigmatizing Terminology for the Disease and Its Treatment: Addiction, Substance Use Disorder, and Medication. J Addict Med. 2017 Jul/Aug; 11(4):246-247. PMID: 28759546.
  9. Lasser KE, Hanchate AD, McCormick D, Walley AY, Saitz R, Lin MY, Kressin NR. Massachusetts Health Reform''s Effect on Hospitalizations with Substance Use Disorder-Related Diagnoses. Health Serv Res. 2017 May 19.View Related Profiles. PMID: 28523674.
  10. Nolan S, Walley AY, Heeren TC, Patts GJ, Ventura AS, Sullivan MM, Samet JH, Saitz R. HIV-infected individuals who use alcohol and other drugs, and virologic suppression. AIDS Care. 2017 Sep; 29(9):1129-1136.View Related Profiles. PMID: 28513200.
Showing 10 of 249 results. Show More

This graph shows the total number of publications by year, by first, middle/unknown, or last author.

Bar chart showing 249 publications over 25 distinct years, with a maximum of 24 publications in 2007

YearPublications
19911
19921
19942
19953
19973
19983
19996
20005
20015
20024
20036
20046
20058
200611
200724
200812
20098
201020
20117
201216
201317
201423
201518
201619
201721
Contact for Mentoring:

801 Massachusetts Ave Crosstown Center
Boston MA 02118
Google Map


Saitz's Networks
Click the "See All" links for more information and interactive visualizations
Concepts
_
Co-Authors
_
Similar People
_
Same Department